drugset / Trial / NCT07310628

Comparison of Analgesic Efficacy of Intrathecal Levobupivacaine With and Without Oral Tizanidine in Lower Limb Surgeries: A Prospective Randomized Study

NCT07310628

RandomizedCrossoverDouble-blindPrevention

Summary

Tizanidine, alpha-2 adrenergic receptor agonist, provides analgesic and hemodynamic benefits, which could enhance the efficacy of local anaesthetics. This randomized controlled trial examines the effectiveness of oral tizanidine as an adjunct to intrathecal levobupivacaine for spinal anaesthesia in lower limb surgeries

Timeline

Start
2022-08-20
Primary completion
2025-07-10
Completion
2025-08-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Tizanidine Small molecule 4 mg Oral

Indications